International Flavors & Fragrances Inc.
84.31USD
-1.3100 (-1.53%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.8▼ | $1.14 | 0 | 12 |
| Next quarter | $0.67▼ | $0.94 | 1 | 11 |
| Current year | $3.24▼ | $4.49 | 0 | 12 |
| Next year | $3.96▼ | $4.8 | 1 | 11 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.12 | $0.82 | -0.30 (-26.6%) |
| 2026-03-31 | $1.07 | $1.25 | +0.18 (+16.5%) |
| 2025-12-31 | $0.83 | $0.8 | -0.03 (-3.8%) |
| 2025-09-30 | $1.02 | $1.05 | +0.03 (+3.3%) |
187 ratings from 23 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $90 $96 | Aug 7, 2026 |
| UBS | Maintained | Neutral | $84 $91 | Aug 6, 2026 |
| Benchmark | Maintained | Buy | $100 $105 | Aug 6, 2026 |
| Morgan Stanley | Maintained | Overweight | $93 $95 | Jul 1, 2026 |
| Argus Research | Maintained | Buy | $80 $85 | Jun 30, 2026 |
| Citigroup | Maintained | Buy | $96 $88 | Jun 24, 2026 |
| Benchmark | Initiated | Buy | $100 | Jun 9, 2026 |
| Barclays | Maintained | Overweight | $80 $90 | May 8, 2026 |
| Citigroup | Maintained | Buy | $90 $96 | May 7, 2026 |
| JP Morgan | Maintained | Overweight | $90 $92 | May 7, 2026 |
| Oppenheimer | Maintained | Outperform | $88 $90 | May 7, 2026 |
| Oppenheimer | Maintained | Outperform | $97 $88 | Apr 22, 2026 |
| Barclays | Maintained | Overweight | $91 $80 | Apr 14, 2026 |
| Citigroup | Maintained | Buy | $100 $90 | Apr 13, 2026 |
| UBS | Maintained | Neutral | $85 $75 | Apr 9, 2026 |
| Barclays | Maintained | Overweight | $78 $91 | Feb 17, 2026 |
| Mizuho | Maintained | Outperform | $85 $92 | Feb 17, 2026 |
| Citigroup | Maintained | Buy | $83 $95 | Feb 13, 2026 |
| Oppenheimer | Upgraded from Perform | Outperform | $97 | Feb 13, 2026 |
| Wells Fargo | Maintained | Overweight | $85 $100 | Feb 13, 2026 |
| Mizuho | Maintained | Outperform | $75 $85 | Feb 12, 2026 |
| Argus Research | Maintained | Buy | $70 $80 | Jan 22, 2026 |
| Citigroup | Maintained | Buy | $77 $83 | Jan 21, 2026 |
| UBS | Maintained | Neutral | $68 $71 | Jan 12, 2026 |
| Barclays | Maintained | Overweight | $72 $75 | Nov 7, 2025 |
79 filings from 25 insiders · 31 buy / 5 sell over 6m
Officers and directors of IFF, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| TELES DE MENDONCA ANA PAULAOfficer | Sell | 5.7k | $83.19 | $476k | Aug 17, 2026 |
| BIRENKRANT MARCOfficer | Sell | 1.0k | $85.00 | $85k | Aug 7, 2026 |
| DEVEAU MICHAELOfficer | Sell | 8.8k | $85.55 | $755k | Aug 6, 2026 |
| FRIBOURG PAUL JDirector | Buy | 273.5k | $74.28 | $20.32M | Jun 1, 2026 |
| FINZEL RALFOfficer | Other | 1.3k | — | — | May 4, 2026 |
| TELES DE MENDONCA ANA PAULAOfficer | Other | 708 | — | — | May 4, 2026 |
| DEVEAU MICHAELChief Financial Officer | Other | 884 | — | — | May 4, 2026 |
| BIRENKRANT MARCOfficer | Other | 389 | — | — | May 4, 2026 |
| BORG DEBORAHOfficer | Other | 1.8k | — | — | May 4, 2026 |
| FINZEL RALFOfficer | Other | 2.0k | — | — | May 1, 2026 |
| O'BYRNE KEVINDirector | Other | 4.3k | — | — | May 1, 2026 |
| ARORA YUVRAJOfficer | Other | 3.6k | — | — | May 1, 2026 |
| TELES DE MENDONCA ANA PAULAOfficer | Other | 1.6k | — | — | May 1, 2026 |
| DEVEAU MICHAELChief Financial Officer | Other | 1.4k | — | — | May 1, 2026 |
| BIRENKRANT MARCOfficer | Other | 397 | — | — | May 1, 2026 |
| ICAHN BRETTDirector | Other | 1.7k | — | — | May 1, 2026 |
| KHAN MEHMOODDirector | Other | 2.6k | — | — | May 1, 2026 |
| DROSOS VIRGINIA COKMANDirector | Other | 2.3k | — | — | May 1, 2026 |
| BORG DEBORAHOfficer | Other | 2.4k | — | — | May 1, 2026 |
| MULLIGAN RICHARD CHARLES PH.DDirector | Other | 1.7k | — | — | May 1, 2026 |
No analyst notes on IFF yet.
Analyst Ratings
18 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 10 | 5 | 0 | 0 | Buy2.00 |
| 1 mo ago | 5 | 11 | 4 | 0 | 0 | Buy1.95 |
| 2 mo ago | 5 | 11 | 4 | 0 | 0 | Buy1.95 |